Cardiac risks and management of complications in pregnant women with congenital heart disease

Future Cardiology

Volumn 8, Issue 2, 2012, Pages 315-327

  Hatton, Rachael ^a   Colman, Jack M ^a   Sermer, Mathew ^a   Grewal, Jasmine ^a   Silversides, Candice K ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

congenital heart disease; outcomes; pregnancy; risk

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE; AMIODARONE; ATENOLOL; BISOPROLOL; CANDESARTAN; CAPTOPRIL; CLOPIDOGREL; DIGOXIN; DILTIAZEM; ENALAPRIL; ESTROGEN; FLECAINIDE; FUROSEMIDE; GLYCERYL TRINITRATE; HEPARIN; HYDRALAZINE; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IRBESARTAN; LABETALOL; LOW MOLECULAR WEIGHT HEPARIN; METHYLDOPA; METOPROLOL; PROGESTERONE; PROPRANOLOL; RAMIPRIL; SOTALOL; UNINDEXED DRUG; VALSARTAN;

ANEMIA; AORTA DISSECTION; AORTA VALVE STENOSIS; BED REST; BIRTH DEFECT; BRADYCARDIA; CARDIOVASCULAR RISK; CARDIOVERSION; CLINICAL ASSESSMENT; CONGENITAL HEART DISEASE; CONGENITAL MALFORMATION; CONTRACEPTION; CONTRACTURE; DELIVERY; EISENMENGER COMPLEX; FEMALE; FETUS DEATH; FETUS DISEASE; FETUS HEART RATE; FETUS OUTCOME; FONTAN PROCEDURE; FRAGILITY FRACTURE; GOITER; GREAT VESSELS TRANSPOSITION; GROWTH RETARDATION; HEART ARREST; HEART ARRHYTHMIA; HEART FAILURE; HEART HEMODYNAMICS; HEART STRESS; HIGH RISK PREGNANCY; HUMAN; HYPERTHYROIDISM; HYPOGLYCEMIA; HYPOSPADIAS; HYPOTENSION; HYPOTHYROIDISM; INTRAUTERINE CONTRACEPTIVE DEVICE; INTRAUTERINE GROWTH RETARDATION; JOINT MALFORMATION; KIDNEY DYSPLASIA; LABOR; LOW BIRTH WEIGHT; LUNG HYPOPLASIA; LUPUS LIKE SYNDROME; MARFAN SYNDROME; MATERNAL CARE; MEDICAL SPECIALIST; MOTHER FETUS RELATIONSHIP; OLIGOHYDRAMNIOS; OSTEOPOROSIS; PATIENT COUNSELING; PATIENT SAFETY; POSTNATAL CARE; PRACTICE GUIDELINE; PREGNANCY COMPLICATION; PREGNANCY TERMINATION; PREMATURITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SIDE EFFECT; SKULL DEFECT; STENT; TACHYCARDIA; TERATOGENICITY; THROMBOCYTOPENIA; TOCOLYSIS; TRANSLUMINAL VALVULOPLASTY; TREATMENT INDICATION;

AORTIC VALVE STENOSIS; CARDIAC OUTPUT; DECISION MAKING; EISENMENGER COMPLEX; FEMALE; HEART DEFECTS, CONGENITAL; HEMODYNAMICS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; RISK ASSESSMENT; RISK FACTORS; TRANSPOSITION OF GREAT VESSELS; WOMEN'S HEALTH;

EID: 84858680277     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/fca.12.18     Document Type: Review

References (86)

1. Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation 115, 163-172 (2007 (Pubitemid 46105714)
2. Warnes CA, Liberthson R, Danielson GK et al. Task force 1: the changing profile of congenital heart disease in adult life. JACC 37(5), 1161-1198 (2008
3. Moons P, Bovijn L, Budts W, Belmans A, Gewillig M. Temporal trends in survival to adulthood among patients born with congenital head disease from 1970 to 1992 in Belgium. Circulation 122, 2264-2272 (2010
4. Karamlou T, Diggs B, McCrindle B, Welke K. A growing problem: maternal death and peripartum complications are higher in women with grown-up congenital heart disease. Ann. Thorac. Surg. 92(6), 2193-2199 (2011
5. Siu SC, Colman JM, Sorensen S et al. Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease. Circulation 105, 2179-2184 (2002 (Pubitemid 34517162)
6. Opotowsky AR, Siddiqi OK, D'Souza B, Webb GD, M Fernandes SM, Landzberg MJ. Maternal cardiovascular events during childbirth in women with congenital heart disease. Heart doi:10.1136/ heartjnl-2011-300828 (2011) (Epub ahead of print
7. Kovacs AH, Harrison JL, Colman JM, Sermer M, Siu SC, Silversides CK. Pregnancy and contraception in congenital heart disease: what women are not told. J. Am. Coll. Cardiol. 52(7), 577-578 (2008
8. Vigl M, Kaemmerer M, Seifert-Klauss V et al. Contraception in women with congenital heart disease. Am. J. Cardiol. 106(9), 1317-1321 (2010
9. Silversides CK, Sermer M, Siu SC. Choosing the best contraceptive method for the adult with congenital heart disease. Curr. Cardio. Rep. 11, 298-305 (2009
10. Thorne S, MacGregor A, Nelson-Piercy C. Risks of contraception and pregnancy in heart disease. Heart 92, 1520-1525 (2006 (Pubitemid 44578860)
11. Pritchard JA. Changes in the blood volume during pregnancy and delivery. Anesthesiology 26(4), 393-399 (1965
12. Hunter S, Robson S. Adaptation of the maternal heart in pregnancy. Br. Heart J. 540-543 (1992 (Pubitemid 23001727)
13. Easterling TR, Benedetti TJ, Schmucker BC, Millard SP. Maternal hemodynamics and normal and preeclamptic pregnancies: a longitudinal study. Obstet. Gynecol. 76, 1061-1069 (1990
14. Gilson GJ, Mosher MD, Conrad KP. Systemic Hemodynamics and oxygen transport during pregnancy in chronically instrumented, conscious rats. Am. J. Physiol. H1911-H1918 (1992 (Pubitemid 23030748)
15. Gilson GJ, Samaan S, Crawford M, Qualls CR, Curet LB. Changes in hemodynamics, ventricular remodeling and ventricular contractility during normal pregnancy: a longitudinal study. Obstet. Gynecol. 89, 957-962 (1997 (Pubitemid 27220462)
16. Robson SC, Hunter S, Boys RJ, Dunlop W. Serial study of factors influencing cardiac output during human pregnancy. Am. J. Physiol. H1060-H1065 (1989
17. Karamermer Y, Roos-Hesselink JW. Pregnancy and adult congenital heart disease. Expert Rev. Cardiovasc. Ther. 5(5), 859-869 (2007 (Pubitemid 47496679)
18. Hennessy TG, MacDonald D, Hennessy MS et al. Serial changes in cardiac output during normal pregnancy: a Doppler ultrasound study. Euro. J. Obstet. Gynecol. 70, 117-122 (1996 (Pubitemid 27046609)
19. Robson SC, Dunlop W, Boys RJ, Hunter S. Cardiac output during labour. Br. Med J. 295, 1169-1172 (1987 (Pubitemid 17154219)
20. Silversides CK, Kiess M, Beauchesne L et al. Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: outflow tract obstruction, coarctation of the aorta, tetralogy of Fallot, Ebstein anomaly and Marfan syndrome. Can. J. Cardiol. 26(3), e80-e97 (2010
21. Warnes CA, Williams RG, Bashore TM et al. ACC/AHA 2008 Guidelines for the management of adults with congenital heart disease. Circulation 118, e714-e833 (2008
22. Regitz-Zagrosek V, Lundqvist C, Borghi C et al. ESC Guidelines on the Management of Cardiovascular Diseases During Pregnancy. Eur. Heart J. doi:10.1093/eurheartj/ehr218 (2011) (Epub ahead of print
23. Baumgartner H, Bonhoeffer P, De Groot NMS et al. ESC guidelines for the management of grown-up congenital heart disease (New Version 2010). Euro. Heart J. 31, 2915-2957 (2010
24. Siu SC, Sermer M, Colman J et al. Prospective multicentre study of pregnancy outcomes in women with heart disease (CARPREG study). Circulation 104, 515-521 (2002
25. Khairy P, Ouyang DW, Fernandes SM, Lee-Parritz A, Economy KE, Landzberg MJ. Pregnancy outcomes in women with congenital heart disease. Circulation 113, 517-524 (2006
26. Drenthen W, Boersma E, Balci A et al. Predictors of pregnancy complications in women with congenital heart disease (ZAHARA study). Euro. Heart J. 31(17), 2124-2132 (2010
27. Liu GK, Silversides CK, Khairy P et al. Heart rate response during exercise and pregnancy outcome in women with congenital heart disease. Circulation 123, 242-248 (2011
28. Drenthen W, Pieper PG, Roos-Hesselink JW et al. Outcome of pregnancy in women with congenital heart disease. JACC 49(24), 2303-2311 (2007 (Pubitemid 46891708)
29. Nora JJ, Nora AH. Maternal transmission of congenital heart diseases: new recurrence risk figures and questions of cytoplasmic inheritance and vulnerability to teratogens. Am. J. Cardiol. 59, 459-463 (1987 (Pubitemid 17032903)
30. Burchill L, Greenway S, Silversides CK, Mital S. Genetic counselling in adult congenital heart disease: what is the role? Curr. Cardiol. Rep. 13(4), 347-355 (2011
31. Lip GYH, Beevers M, Churchill D, Shaffer LM, Beevers DG. Effect of atenolol on birth weight. Am. J. Cardiol. 79, 1436-1439 (1997
32. Lydakis C, Lip GYH, Beevers M, Beevers DG. Atenolol and foetal growth in pregnancies complicated by hypertension. Am. J. Hypertens. 12, 541-547 (1999 (Pubitemid 29268384)
33. Brooke BS, Habashi JP, Judge DP. Angiotensin II blockade and aortic root dilatation in marfan syndrome. NEJM 358, 2787-2795 (2008 (Pubitemid 351930853)
34. Immer FF, Bansi AG, Immer-Bansi AS. Aortic dissection in pregnancy: analysis of risk factors and outcome. Ann. Thorac. Surg. 76, 309-314 (2003 (Pubitemid 36819774)
35. Goland S, Barakat M, Khatri N, Elkayam U. Pregnancy in Marfan syndrome: maternal and foetal risk and recommendations for patient assessment and management. Cardiol. Rev. 17, 253-262 (2009
36. Goland S, Elkayam U. Cardiovascular problems in pregnant women with Marfan syndrome. Circulation 119, 619-623 (2009
37. Goldszmitz E, Macarthur A, Silversides C, Colman J, Sermer M, Siu S. Anaesthetic management of a consecutive cohort of women with heart disease for labour and delivery. Int. J. Obstet. Anesth. 19, 266-272 (2010
38. Ouyang DW, Khairy P, Fernandes SM, Landzberg MJ, Economy KE. Obstetric outcomes in women with congenital heart disease. Int. J. Cardiol. 144(2), 195-199 (2010
39. Tanous D, Siu SC, Mason J et al. B-Type Natriuretic peptide in pregnant women with heart disease. JACC 56, 1247-1253 (2010
40. Van den Hoek TL, Morrison LJ, Shuster M et al. Part 12: cardiac arrest in special situations: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 122, S829-S861 (2010
41. Gleicher N, Midwall J, Hochberger D, Jaffin H. Eisenmengers syndrome and pregnancy. Obstet. Gynecol. 34(10), 721-741 (1979
42. Bonnin M, Mercier FJ, Sitbon O et al. Severe pulmonary hypertension during pregnancy: mode of delivery and anaesthetic management of 15 consecutive cases. Anesthesiology 102, 1133-1137 (2005 (Pubitemid 40745831)
43. Bédard E, Dimopoulos K, Gatzoulis MA. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? Euro. Heart J. 30, 256-265 (2009
44. Thorne S, Nelson-Piercy C, MacGregor A et al. Pregnancy and contraception in heart disease and pulmonary arterial hypertension. J. Fam. Plann. Reprod. Health Care 32(2), 75-81 (2006
45. Kiely DG, Condliffe R, Webster V et al. Improved survival in pregnancy and pulmonary hypertension using a multiprofessional approach. BJOG 117, 565-574 (2010
46. Budts W, Van Pelt N, Gillyns H et al. Residual pulmonary vasoactivity to inhaled nitric oxide in patients with severe obstructive pulmonary hypertension and Eisenmengers syndrome. Heart 86, 553-558 (2001 (Pubitemid 32999869)
47. Canobbio MM, Mair DD, Van Der Velde M, Koos BJ. Pregnancy outcomes after the Fontan repair. JACC 28(3), 763-767 (1996 (Pubitemid 26288662)
48. Drenthen W, Pieper PG, Roos-Hesselink JW. Pregnancy and delivery in women after Fontan palliation. Heart 92, 1290-1294 (2006 (Pubitemid 44298884)
49. Loeys BL, Dietz HC, Braverman AC. Revised Ghent nosology for the Marfan syndrome. J. Med. Genet. 47, 476-485 (2010
50. Meijboom LJ, Drenthen W, Pieper PG. Obstetric complications in Marfan syndrome. Int. J. Cardiol. 110, 53-59 (2006 (Pubitemid 44251059)
51. McDermott CD, Sermer M, Siu SC, David TE, Colman JM. Aortic dissection complicating pregnancy following prophylactic aortic root replacement in a woman with Marfan Syndrome. Int. J. Cardiol. 120(3), 427-430 (2007 (Pubitemid 47069556)
52. Meijboom LJ, Vos FE, Timmermans J, Boers GH, Zwinderman AH, Mulder BJM. Pregnancy and aortic root growth in the Marfan syndrome: a prospective study. Euro. Heart J. 26, 914-920 (2005 (Pubitemid 40676572)
53. Pratt Rossiter J, Repke JT, Morales AJ, Murphy EA, Pyeritz RE. Prospective evaluation of pregnancy in the Marfan syndrome. Am. J. Obstet. Gynecol. 173, 1599-1603 (1995
54. Schwerzmann M, Salehian O, Harris L et al. Ventricular arrhythmias and sudden death in adults after a Mustard operation for transposition of the great arteries. Euro. Heart J. 30, 1873-1879 (2009
55. Guédès A, Mercier LA, Leduc L, Bérubé L, Marcotte F, Dore A. Impact of pregnancy on the systemic right ventricle after a mustard operation for transposition of the great arteries. JACC 44(2), 433-437 (2004 (Pubitemid 38950607)
56. Gelson E, Curry R, Gatzoulis MA et al. Pregnancy in women with a systemic right ventricle after surgical and congenitally corrected transposition of the great arteries. Euro. J. Obstet. Gynecol. Reprod. Biol. 155, 146-149 (2011
57. Canobbio MM, Morris CD, Graham TP, Landzberg MJ. Pregnancy outcomes after atrial repair for transposition of the great arteries. Am. J. Cardiol. 98, 668-672 (2006 (Pubitemid 44233468)
58. Connolly HM, Grogan M, Warnes CA. Pregnancy among women with congenitally corrected transposition of the great arteries. JACC 33, 1692-1695 (1999
59. Therrien J, Barnes I, Somerville J. Outcome of pregnancy in congenitally corrected transposition of the great arteries. Am. J. Cardiol. 84, 820-824 (1999 (Pubitemid 29469793)
60. Robins K, Lyons G. Supraventricular tachycardia in pregnancy. Br. J. Anaesth. 92(1), 140-143 (2004 (Pubitemid 38054663)
61. Garratt C, Linker N, Griffith M, Ward D, Camm AJ. Comparison of adenosine and verapamil for termination of paroxysmal junctional tachycardia. Am. J. Cardiol. 64, 1310-1316 (1989 (Pubitemid 20000081)
62. Nistri S, Sorbo MD, Martin M, Palisi M, Scognamiglio R, Thiene G. Aortic root dilatation in young men with normally functioning bicuspid aortic valves. Heart 82, 19-22 (1999 (Pubitemid 29309229)
63. McKellar SH, MacDonald RJ, Michelena HI, Connolly HM, Sundt III TM. Frequency of cardiovascular events in women with a congenitally bicuspid aortic valve in a single community and effect of pregnancy on events. Am. J. Cardiol. 107, 96-99 (2011
64. Hameed A, Karaalp I, Tummala PP et al. The effect of valvular heart disease on maternal and foetal outcome of pregnancy. JACC 37, 893-899 (2001 (Pubitemid 32202460)
65. Silversides CK, Colman JM, Sermer M, Farine D, Siu SC. Early and intermediate-term outcomes of pregnancy with congenital aortic stenosis. Am. J. Cardiol. 91, 1386-1389 (2003 (Pubitemid 36593495)
66. Yap SC, Drenthen W, Peiper PG et al. Risk or complications during pregnancy in women with congenital aortic stenosis. Int. J. Cardiol. 126, 240-246 (2008 (Pubitemid 351611667)
67. Vahanian A, Baumgartner H, Bax J et al. Guidelines on the management of valvular heart disease: the taskforce on the management of valvular heart disease of the European Society of Cardiology. Euro. Heart J. 28, 230-268 (2007 (Pubitemid 46276943)
68. Presbitero P, Prever SB, Brusca A. Interventional cardiology in pregnancy. Euro. Heart J. 17, 182-188 (1996 (Pubitemid 26118260)
69. Weiss BM, von Segesser LK, Alon E, Seifert B, Turina MI. Outcome of cardiovascular surgery and pregnancy: a systematic review of the period 1984-1996. Am. J. Obstet. Gynecol. 179(6 Pt 1), 1643-1653 (1998 (Pubitemid 29028415)
70. Chan WS, Anand S, Ginsberg JS. Anticoagulation in pregnant women with mechanical heart valves. Arch. Intern. Med. 160, 191-196 (2000
71. Pieper PG, Baki A, Van Dijk AP. Pregnancy in women with prosthetic heart valves. Neth. Heart J. 16, 406-411 (2008
72. Hirsh J, Cade JF, Gallus AS. Foetal effects of coumadin administered during pregnancy. Blood 36, 623-627 (1970
73. Vitale N, De Feo M, Salvatore L, Pollice A, Tedesco N, Cotrufo M. Dose-dependent foetal complications of warfarin in pregnant women with mechanical heart valves. JACC 33, 1637-1641 (1999
74. Salazar E, Izaguirre R, Verdejo J, Mutchinik O. Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomenon in pregnant patients with mechanical cardiac valve prostheses. JACC 27(7), 1698-1703 (1996 (Pubitemid 126334709)
75. Cotrufo M, De Feo M, De Santo LS et al. Risk of warfarin during pregnancy with mechanical valve prostheses. Obstet. Gynecol. 99, 35-40 (2002 (Pubitemid 34075465)
76. Iturbe-Alessio I, Del Carmen Fonseca M, Mutchinik O, Santos MA, Zajarías A, Salazar E. Risks of anticoagulant therapy in women with artificial heart valves. N. Engl. J. Med. 315, 1390-1393 (1986 (Pubitemid 17055412)
77. Kraus AP, Perlow S, Singer K. Danger of dicumarol treatment in pregnancy. JAMA 139, 758-761 (1949
78. Natelson EA, Lynch EC, Alfred CP, Gross JB. Heparin induced thrombocytopenia: an unexpected response to treatment of consumption coagulopathy. Ann. Intern. Med. 71(6), 1121-1125 (1969
79. Dahlman TC. Osteoporotic fractures and recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am. J. Obstet. Gynecol. 107, 1240-1246 (1993
80. Muir JM, Hirsh J, Weitz JI, Andrew M, Young E, Shaughnessy SG. A histomorphometric comparison of the effects of heparin and low-molecular-weight heparin on cancellous bones in rats. Blood 89, 3236-3242 (1997
81. Casele HL. The use of heparin and low molecular weight heparin in pregnancy. Clin. Obstet. Gynecol. 49(4), 895-905 (2006 (Pubitemid 44691212)
82. Yinon Y, Siu SC, Warshafsky C et al. Use of Low molecular weight heparin in pregnant women with mechanical heart valves. Am. J. Cardiol. 104, 1259-1263 (2009
83. McLintock C, McCowen LME, North RE. Maternal complications and pregnancy outcomes in women with mechanical heart valves treated with enoxaparin. Br. J. Obstet. Gynecol. 116, 1585-1592 (2009
84. Elkayam U, Bitar F. Valvular heart disease and pregnancy: part II. prosthetic valves. JACC 46(3), 403-410 (2005 (Pubitemid 41040278)
85. Bonow RO, Carabello BA, Chatterjee K et al. ACC/AHA Guidelines for the Management of Patients with Valvular Heart Disease. Circulation 114, e84-e231 (2006
86. Hirsh J, Guyatt G, Albers GW, Harrington R, Schünemann HJ. Executive summary: American College of Chest Physicians evidence based practice guidelines (8th Edition). Chest 133, S71-S109 (2008)